Skip to content
Back to Publications

Deep learning-based quantification of collagen and associated features from H&E-stained whole slide pathology images across cancer types

Abstract

Background:

Collagen, a major component of the extracellular matrix, undergoes reorganization during tumorigenesis. However, visualizing collagen in tissue currently requires special stains (complicated by variability) or imaging (hindered by reliability, cost, and throughput). Here, we describe an approach to exhaustively detect and quantify collagen in hematoxylin and eosin (H&E)-stained images.

Methods:

Polarization images of picrosirius red-stained slides served as ground-truth training images for development of inferred quantitative multimodal anisotropy imaging (iQMAI), a deep learning model that infers collagen directly from H&E-stained whole-slide images. Individual collagen fibers were extracted after iQMAI inference, and features describing collagen intensity and fiber morphology were computed. iQMAI outputs were measured against polarization imaging and were compared to tissue composition, gene expression, and survival in lung adenocarcinoma, lung squamous cell carcinoma, hepatocellular carcinoma, and pancreatic adenocarcinoma datasets from the cancer genome atlas.

Results:

iQMAI-derived collagen predictions and fiber features (fiber tortuosity, length, width, and relative angle) are correlated with polarization-based measurements. In pancreatic adenocarcinoma, fiber density and width are negatively associated with the LRRC-15 gene expression signature, and increased fiber width is associated with longer overall survival.

Conclusion:

iQMAI, a deep learning model identifying collagen in H&E-stained images, allows exhaustive, spatially-resolved quantification of collagen morphology, enabling investigation of the interplay between collagen and the tumor microenvironment. The association of collagen features with immunosuppressive fibroblasts and outcome in pancreatic adenocarcinoma demonstrates the potential of iQMAI. Understanding the relationship between collagen, tumor composition, and disease progression may aid the development of effective oncology therapies.



Authors

  • Nguyen and Zhang et al.